4
Changes in Ownership
Monte Rosa Therapeutics, Inc. Filed Acc 0001193125-26-253472
President & CEO sold 5,466 shares at an average $19.44 ($106,253)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Warmuth Markus · President & CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-01 | Sale : show line 1 in the form 10b5-1 | −4,998 | $19.41 | $97,021 | 595,006 | D |
| 2026-06-01 | Sale : show line 2 in the form 10b5-1 | −468 | $19.73 | $9,232 | 594,538 | D |
| Open-market sales · 5,466 sh · avg $19.44 · $106,253 | ||||||
Loading xslF345X06/ownership.xml…